Deshko adds that traditionally, sea moss has been boiled into a gel and used in foods or as a natural remedy. However, ...

Manufacturer Novo Nordisk has partnered with telehealth companies and other weight-loss groups to increase access to the pill, starting at $149 a month Novo Nordisk/FDA The Wegovy pill, which is ...

Americans can now purchase a starter dose of Novo Nordisk’s weight loss drug Wegovy in pill form, the company announced Monday, pledging widespread availability. The 1.5 milligram starter dose of a ...

Weight-loss drug Wegovy is now available in the form of a pill in the United States, the Scandinavian drug-maker Novo Nordisk announced on Monday, Jan. 5. The first-of-its kind pill offers 1.5 and 4 ...

The Wegovy pill is the first and only oral GLP-1 for weight loss in adults. The first and only oral GLP-1 for weight loss in adults is now available to consumers. Drugmaker Novo Nordisk announced ...

Americans can now purchase the starter dose of blockbuster weight-loss drug Wegovy as a pill, drug maker Novo Nordisk announced Monday. Other strengths will be available as pills by the end of the ...

A pill version of the blockbuster weight-loss medication Wegovy is rolling out in the U.S., and people are already actively navigating prescriptions. Experts say that a pill version of the high-demand ...

Novo Nordisk launched the first GLP-1 weight-loss pill Monday with a pledge that manufacturing investments will enable the drugmaker to avoid the type of shortages that plagued the rollout of its ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new ...

The new Wegovy pill was just approved in the US—and it’s the first oral GLP-1 for weight management on the market. Trials suggest it’s approximately as effective as the injectable form, and it has ...

LONDON, Dec 29 (Reuters) - Ask executives in the healthcare industry about the future market for weight-loss drugs and the analogies are telling: monthly GLP-1 medicine subscriptions like a streaming ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk plans to ...